首页> 美国卫生研究院文献>The Journal of Physiology >The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits
【2h】

The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits

机译:Kir6.2-F333I突变差异调节由SUR1或SUR2亚基组成的KATP通道

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in Kir6.2, the pore-forming subunit of the KATP channel, that reduce the ability of ATP to block the channel cause neonatal diabetes. The stimulatory effect of MgATP mediated by the regulatory sulphonylurea receptor (SUR) subunit of the channel may also be modified. We compared the effect of the Kir6.2-F333I mutation on KATP channels containing SUR1, SUR2A or SUR2B. The open probability of Kir6.2/SUR1 channels, or a C-terminally truncated form of Kir6.2 expressed in the absence of SUR, was unaffected by the mutation. However, that of Kir6.2/SUR2A and Kir6.2/SUR2B channels was increased. In the absence of Mg2+, ATP inhibition of all Kir6.2-F333I/SUR channel types was reduced, although SUR1-containing channels were reduced more than SUR2-containing channels. These results suggest F333 is involved in differential coupling of Kir6.2 to SUR1 and SUR2. When Mg2+ was present, ATP blocked SUR2A channels but activated SUR2B and SUR1 channels. Activation by MgGDP (or MgADP) was similar for wild-type and mutant channels and was independent of SUR. This indicates Mg-nucleotide binding to SUR and the transduction of binding into opening of the Kir6.2 pore are unaffected by the mutation. The data further suggest that MgATP hydrolysis by the nucleotide-binding domains of SUR1 and SUR2B, but not SUR2A, is enhanced by the F333I mutation in Kir6.2. Taken together, our data suggest the region of the C terminus within which F333 lies is involved in more than one type of functional interaction with SUR, and that F333 interacts differentially with SUR1 and SUR2.
机译:Kir6.2(KATP通道的成孔亚基)中的突变降低了ATP阻断通道的能力,从而导致了新生儿糖尿病。由通道的调节性磺酰脲受体(SUR)亚基介导的MgATP的刺激作用也可能被修饰。我们比较了Kir6.2-F333I突变对包含SUR1,SUR2A或SUR2B的KATP通道的影响。 Kir6.2 / SUR1通道的开放概率,或在不存在SUR的情况下表达的Kir6.2的C端截短形式不受突变影响。但是,增加了Kir6.2 / SUR2A和Kir6.2 / SUR2B通道的频道。在缺少Mg 2 + 的情况下,尽管所有含SUR1的通道比含SUR2的通道减少得更多,但所有Kir6.2-F333I / SUR通道类型的ATP抑制作用都降低了。这些结果表明,F333参与了Kir6.2与SUR1和SUR2的差分偶联。当存在Mg 2 + 时,ATP阻止了SUR2A通道,但激活了SUR2B和SUR1通道。 MgGDP(或MgADP)的激活与野生型和突变型通道相似,并且独立于SUR。这表明Mg-核苷酸与SUR的结合以及结合的转化进入Kir6.2孔的开口不受突变的影响。数据进一步表明,Sir1和SUR2B的核苷酸结合域(而非SUR2A)的MgATP水解通过Kir6.2中的F333I突变得到增强。两者合计,我们的数据表明F333所在的C末端区域参与与SUR的一种以上类型的功能相互作用,并且F333与SUR1和SUR2差异性相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号